1. |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
|
2. |
Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61(2): 69-90.
|
3. |
Coleman MP, Gatta G, Verdecchia A, et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol, 2003, 14(5): 128-149.
|
4. |
Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 2009, 30(7): 1073-1081.
|
5. |
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet, 2001, 357: 539-545.
|
6. |
Yeşil A, Senateş E, Bayoğlu IV, et al. Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut Liver, 2011, 5(4): 460-467.
|
7. |
Gunebakmaz O, Kaya MG, Duran M, et al. Red blood cell distribution width in 'non-dippers' versus 'dippers'. Cardiology, 2012, 123(3): 154-159.
|
8. |
Albayrak S, Zengin K, Tanik S, et al. Red cell distribution width as a predictor of prostate cancer progression. Asian Pac J Cancer Prev, 2014, 15(18): 7781-7784.
|
9. |
Wells G, Shea BJ, O’Connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric, 2014, 18(6): 727-734.
|
10. |
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring in-consistency in meta-analyses. BMJ, 2003, 327(7414): 557-560.
|
11. |
Chen GP, Huang Y, Yang X, et al. A nomogram to predict prognostic value of red cell distribution width in patients with esophageal cancer. Mediators Inflamm, 2015, 2015: 854670.
|
12. |
Hirahara N, Matsubara T, Kawahara D, et al. Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma. Int J Clin Oncol, 2016, 21(5): 909-919.
|
13. |
吴振江, 吉庆春. 红细胞分布宽度对食管癌预后的影响. 华夏医学, 2016, 29(6): 10-12.
|
14. |
Sun P, Zhang F, Chen C, et al. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China. Oncotarget, 2016, 7(27): 42650-42660.
|
15. |
Wan GX, Chen P, Cai XJ, et al. Elevated red cell distribution width contributes to a poor prognosis in patients with esophageal carcinoma. Clin Chim Acta, 2016, 452: 199-203.
|
16. |
Zhang F, Chen Z, Wang P, et al. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients. Tumour Biol, 2016, 37(7): 9323-9331.
|
17. |
Hu D, Lin X, Chen Y, et al. Preoperative blood-routine markers and prognosis of esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study. Oncotarget, 2017, 8(14): 23841-23850.
|
18. |
Han F, Liu Y, Cheng S, et al. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer. Clin Chim Acta, 2019, 488: 150-158.
|
19. |
Schreiber RD, Old LJ, Smyth MJ, et al. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science, 2011, 331(6024): 1565-70.
|
20. |
Agarwal S. Red cell distribution width, inflammatory markers and cardiorespiratory fitness: results from the National Health and Nutrition Examination Survey. Indian Heart J, 2012, 64(4): 380-387.
|
21. |
McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care, 2009, 12(3): 223-226.
|
22. |
Hébuterne X, Lemarié E, Michallet M, et al. Prevalence of malnutrition and current use of nutrition support in patients with cancer. J Parenter Enteral Nutr, 2014, 38(2): 196-204.
|